James J. Bochnowski
CIK: 0001255743
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Jaguar Health, Inc.
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Dec 11, 2025JAGX
Jaguar Health, Inc.
Award(A)Direct6.4K shares- - Jun 24, 2025JAGX
Jaguar Health, Inc.
Disposition(D)IndirectConvertible Promissory Note
27K shares at avg. $150000.00- - Jun 24, 2025JAGX
Jaguar Health, Inc.
Award(A)IndirectConvertible Promissory Note
28.4K shares at avg. $150000.00- - Jun 24, 2025JAGX
Jaguar Health, Inc.
Award(A)IndirectWarrant to Purchase Common Stock
54.8K shares- - Mar 31, 2025JAGX
Jaguar Health, Inc.
Purchase(P)IndirectWarrant to Purchase Common Stock
27K shares- - Mar 31, 2025JAGX
Jaguar Health, Inc.
Purchase(P)IndirectConvertible Promissory Note
27K shares at avg. $150000.00- - Oct 8, 2024JAGX
Jaguar Health, Inc.
Award(A)DirectStock option (right to buy)
23.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Dec 11, 2025 | JAGX Jaguar Health, Inc. | Award(A) | 6,363 | - | - | Direct |
| Jun 24, 2025 | JAGX Jaguar Health, Inc. | Disposition(D) Convertible Promissory Note | 27,002 | $150000.00 | - | Indirect |
| Jun 24, 2025 | JAGX Jaguar Health, Inc. | Award(A) Convertible Promissory Note | 28,388 | $150000.00 | - | Indirect |
| Jun 24, 2025 | JAGX Jaguar Health, Inc. | Award(A) Warrant to Purchase Common Stock | 54,786 | - | - | Indirect |
| Mar 31, 2025 | JAGX Jaguar Health, Inc. | Purchase(P) Warrant to Purchase Common Stock | 27,002 | - | - | Indirect |
| Mar 31, 2025 | JAGX Jaguar Health, Inc. | Purchase(P) Convertible Promissory Note | 27,002 | $150000.00 | - | Indirect |
| Oct 8, 2024 | JAGX Jaguar Health, Inc. | Award(A) Stock option (right to buy) | 23,200 | - | - | Direct |
1-7 of 7 transactions
About BOCHNOWSKI JAMES J
BOCHNOWSKI JAMES J (SEC CIK 0001255743) files insider reports with the SEC as Director of Jaguar Health, Inc. (JAGX).
Signal8 holds 4 ownership filings by BOCHNOWSKI JAMES J, all Form 4s, filed between Oct 10, 2024 and Dec 15, 2025. Those filings report 7 transactions, from Oct 8, 2024 to Dec 11, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on BOCHNOWSKI JAMES J's filings is in SAN FRANCISCO, CA.
Recent filings by BOCHNOWSKI JAMES J
- Dec 11, 2025: Grant or award of JAGX shares (Form 4, code A).
- Jun 24, 2025: Disposition to issuer transaction of JAGX derivative securities (Form 4, code D).
- Jun 24, 2025: Grants or awards of JAGX derivative securities (2 lines, Form 4, code A).
- Mar 31, 2025: Open-market purchases of JAGX derivative securities (2 lines, Form 4, code P).
- Oct 8, 2024: Grant or award of JAGX derivative securities (Form 4, code A).
Other insiders filing for Jaguar Health, Inc. (JAGX)
- MICEK JOHN, Director
- King Steven R.
- CONTE LISA A
- Wolin Jonathan S.
- Chaturvedi Pravin R, Chief Scientific Officer
- Siegel Jonathan B., Director